Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 24, 2020
[ Tue, Mar 24th 2020
] - WOPRAI
[ Tue, Mar 24th 2020
] - WOPRAI
[ Tue, Mar 24th 2020
] - WOPRAI
[ Tue, Mar 24th 2020
] - WOPRAI
[ Tue, Mar 24th 2020
] - WOPRAI
[ Tue, Mar 24th 2020
] - WOPRAI
[ Tue, Mar 24th 2020
] - WOPRAI
[ Tue, Mar 24th 2020
] - WOPRAI
[ Tue, Mar 24th 2020
] - WOPRAI
Mon, March 23, 2020
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
Chris Cooley Maintained (AVNS) at Buy with Decreased Target to $30 on, Mar 23rd, 2020
Chris Cooley of Stephens & Co., Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $40 to $30 on, Mar 23rd, 2020.
Chris has made no other calls on AVNS in the last 4 months.
There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Chris's Rating of Hold.
This is the rating of the analyst that currently disagrees with Chris
- David Lewis of "Morgan Stanley" Maintained at Sell with Decreased Target to $32 on, Tuesday, December 17th, 2019
Similar Stocks and Investing Articles
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Thu, Mar 05th 2020
] - WOPRAI
[ Thu, Mar 05th 2020
] - WOPRAI
[ Thu, Mar 05th 2020
] - WOPRAI
[ Wed, Mar 04th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Tue, Dec 17th 2019
] - WOPRAI